Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Wide Margin MOV Q1 2026 Earnings EPS Beats Estimates Stock Lifts on Profit Surprise FORA Q1 2026 Earnings Steep EPS Miss Overshadows Quarter as Revenue Remains Undisclosed WidePoint WYY Q1 2026 Earnings EPS Surprises Positively Revenue Not Disclosed Stock Declines 19 EIKN Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Intensifies TPL Q1 2026 Earnings EPS Slightly Beats Estimates Amid Stable Land Operations